2006
DOI: 10.1182/blood-2006-02-003376
|View full text |Cite
|
Sign up to set email alerts
|

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis

Abstract: We previously reported that mice made deficient for the transcriptional factor USF2 fail to express hepcidin 1 and hepcidin 2 genes as a consequence of targeted disruption of the Usf2 gene lying just upstream in the locus. These mice developed an iron overload phenotype with excess iron deposition in parenchymal cells and decreased reticuloendothelial iron. At that time, although the role of USF2 was still confounding, we proposed for the first time the role of hepcidin as a negative regulator of iron absorpti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
188
1
2

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 225 publications
(207 citation statements)
references
References 23 publications
16
188
1
2
Order By: Relevance
“…The lack of significant cardiac dysfunction in our Hamp −/− mice and in other reported mouse models of impaired hepcidin production (29)(30)(31) is in contrast with the clinical characteristics of juvenile hemochromatosis, in which patients develop severe cardiomyopathy (5). This contrast points to possible differences between human and murine cardiomyocytes in iron entry, export, storage, or detoxification pathways.…”
Section: Discussioncontrasting
confidence: 45%
“…The lack of significant cardiac dysfunction in our Hamp −/− mice and in other reported mouse models of impaired hepcidin production (29)(30)(31) is in contrast with the clinical characteristics of juvenile hemochromatosis, in which patients develop severe cardiomyopathy (5). This contrast points to possible differences between human and murine cardiomyocytes in iron entry, export, storage, or detoxification pathways.…”
Section: Discussioncontrasting
confidence: 45%
“…Inadequate levels of hepcidin lead to excessive dietary iron absorption (80), excessive mobilization of macrophage iron stores (81), saturation of transferrin with iron, and the appearance of NTBI in plasma (82). Iron overload is also seen in ␤-thalassemia, a genetic disorder resulting from defective ␤-globin synthesis.…”
Section: Pathological Tissue Iron Overloadmentioning
confidence: 99%
“…Despite normal systemic iron homeostasis and circulating hepcidin levels (99), the specific deletion of hepcidin in cardiomyocytes causes cardiac iron depletion and premature death, attributed to increased ferroportin expression in cardiomyocytes and excessive cellular iron efflux. Mice with global deletion of hepcidin may be protected from cardiac iron depletion by increased levels of circulating iron, including NTBI (81). The deletion of ferroportin in cardiomyocytes yields the opposite phenotype, cardiac iron accumulation, but also results in premature death (100).…”
Section: Local Regulation Of Cellular Iron By Hepcidinmentioning
confidence: 99%
“…In the presence of cytosolic HIF␣, hepcidin is down-regulated and prevented from binding to and internalizing FPT (26,27), thereby increasing the levels of the iron exporter. MPTP treatment alone was observed to result in a decrease of ferroportin levels within the SN (Fig.…”
Section: Phd Inhibition By Dhb Prevents Mptp-induced Losses In Sn Levmentioning
confidence: 99%